$IRON
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
John D. Quisel
CEO
94
Employees
$76.00
Current Price
$25.49M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 9 | $3,351,273.95 | 41,825 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 10 | $5,253,778.91 | 68,961 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 31 | $13,191,054.46 | 168,046 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | Bitterman Kevin Director | Sale | 2,388 | $79.95 | $190,920.60 | View Details |
| Oct 21, 2026 | Bitterman Kevin Director | Sale | 13,783 | $80.23 | $1,105,810.09 | View Details |
| Oct 19, 2026 | Bitterman Kevin Director | Sale | 5,937 | $79.97 | $474,781.89 | View Details |
| Oct 21, 2026 | Bitterman Kevin Director | Sale | 266 | $80.23 | $21,341.18 | View Details |
| Oct 21, 2026 | Bitterman Kevin Director | Sale | 11,470 | $80.23 | $920,238.10 | View Details |
| Oct 20, 2026 | Bitterman Kevin Director | Sale | 2,869 | $79.95 | $229,376.55 | View Details |
| Oct 19, 2026 | Bitterman Kevin Director | Sale | 4,942 | $79.97 | $395,211.74 | View Details |
| Oct 20, 2026 | Bitterman Kevin Director | Sale | 55 | $79.95 | $4,397.25 | View Details |
| Oct 19, 2026 | Bitterman Kevin Director | Sale | 115 | $79.97 | $9,196.55 | View Details |
| Sep 11, 2026 | Bitterman Kevin Director | Sale | 27,136 | $70.11 | $1,902,504.96 | View Details |
| Sep 4, 2026 | Bitterman Kevin Director | Sale | 912 | $79.96 | $72,923.52 | View Details |
| Sep 4, 2026 | Bitterman Kevin Director | Sale | 18 | $79.96 | $1,439.28 | View Details |
| Sep 4, 2026 | Bitterman Kevin Director | Sale | 759 | $79.96 | $60,689.64 | View Details |
| Sep 2, 2026 | Bitterman Kevin Director | Sale | 9 | $80.98 | $728.82 | View Details |
| Sep 1, 2026 | Bitterman Kevin Director | Sale | 70 | $79.95 | $5,596.50 | View Details |
| Sep 2, 2026 | Bitterman Kevin Director | Sale | 26,542 | $80.17 | $2,127,872.14 | View Details |
| Sep 2, 2026 | Bitterman Kevin Director | Sale | 511 | $80.17 | $40,966.87 | View Details |
| Sep 2, 2026 | Bitterman Kevin Director | Sale | 2 | $80.98 | $161.96 | View Details |
| Sep 1, 2026 | Bitterman Kevin Director | Sale | 58 | $79.95 | $4,637.10 | View Details |
| Sep 3, 2026 | Bitterman Kevin Director | Sale | 2,339 | $79.98 | $187,073.22 | View Details |
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$1.63
ActualN/A
Revenue
Estimated$1.88M
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.